Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens
Novel immunotherapeutic approaches to glioma
Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
Dendritic cell defects in patients with cancer: mechanisms and significance
From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy
Immunity to melanoma antigens: from self-tolerance to immunotherapy
Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma
Immunotherapy for prostate cancer
Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
Genetically modified dendritic cells for therapeutic immunity
Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors
Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination